Select Page

About Us


Our Story

Ourobio began as Transfoam, an iGEM research project at the University of Virginia in early 2019 and was spun out in March 2020. Our founders have been working on Ourobio since its inception and have aligned our personal commitments to ocean sustainability and preservation of the outdoors with our company’s commitments to industry and the environment. 


Since June of 2021, Ourobio has operated a rudimentary lab space on the in Charlottesville, Virginia. Check in regularly for new developments!


Mission & Vision

Ourobio’s mission is to develop cutting-edge, bio-based technologies to accelerate decarbonization and eliminate the creation of microplastic pollution.

Our vision is for biomaterials to replace the toxic, petroleum-based chemicals and materials that are difficult to recycle and contributing to many of our world’s environmental and human health issues 

Our Team

Alec Brewer

Alec Brewer

Founder & Chief Executive Officer

Alec is a graduate of the University of Virginia (UVA), holding a B.S. in Biomedical Engineering. Alec has 6 years experience working with startups and small businesses, and is heavily involved in Charlottesville’s synthetic biology, sustainability, and entrepreneurship communities.

In 2019, Alec was elected co-chair of the UVA iGEM synbio research team where he first began working with Transfoam. At Ourobio, Alec oversees long-term technical advancement and strategic outreach to potential partners and industry/trade organizations. In his free time, Alec enjoys spending time outdoors and has recently gotten into longboarding, climbing and trail running. Alec also helps to co-manage a nonprofit startup that is tackling furniture waste and furniture poverty in Charlottesville.

Kobe Rogers

Kobe Rogers

Founder & Chief Operations Officer

Kobe graduated from the University of Virginia with a B.S. in Chemistry with a biochemistry specialization. He has experience developing experimental methods for testing protein expression and high-throughput methods for validating PHB production. Kobe currently leads bioprocess development and material analysis, regularly employing techniques like Gas Chromatography-Mass Spectroscopy, Differential-Scanning Calorimetry, and high-throughput fluorometric analysis.